Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients

被引:29
|
作者
Lang, H
Schlitt, HJ
Schmidt, H
Flemming, P
Nashan, B
Scheumann, GFW
Oldhafer, KJ
Manns, MP
Raab, R
机构
[1] Univ Essen Gesamthsch Klinikum, Klin & Poliklin Allgemein & Transplantat Chirurg, D-45122 Essen, Germany
[2] Med Hsch Hannover, Abdominal & Transplantat Chirurg Klin, D-30625 Hannover, Germany
[3] Med Hsch Hannover, Gastroenterol & Hepatol Abt, D-30625 Hannover, Germany
[4] Med Hsch Hannover, Abt Pathol, D-30625 Hannover, Germany
关键词
liver transplantation; neuroendocrine pancreatic tumors; hepatic metastases;
D O I
10.1007/s004230050216
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Metastatic neuroendocrine pancreatic tumors have a poor prognosis. We have studied retrospectively the efficacy of liver transplantation as ultimate therapy of otherwise untreatable symptomatic neuroendocrine hepatic metastases originating in the pancreas. Methods: We reviewed our experience of liver transplantation (LTx) for hepatic metastases of neuroendocrine pancreatic tumors in ten patients. The indication for liver grafting was seen in cases of irresectable metastases and when patients were suffering from otherwise untreatable tumor-associated symptoms due to massive hormonal release or large intra-abdominal turner bulk. Results: In four patients, the primary tumors had been removed before LTx, in five patients simultaneously with LTx and in one case 46 months after grafting. There was no operative mortality. After hepatectomy and LTx, all patients had complete relief of symptoms and all preoperatively increased hormonal levels returned to normal. In nine of ten patients, the transplant procedure had the potential for cure, whereas, in one patient, the primary tumor had remained in situ at LTx and was removed 46 months later by an R2-resection. At present, nine patients are alive with a median follow-up of 33 months (range 13.5 months to 117 months). The one patient in whom the primary tumor was removed after transplantation died due to massive intra-abdominal tumor spread 68 months after LTx. Currently, two patients are without evidence of disease, but one of them after re-operation because of lymph-node metastases 8 months after transplantation. The longest disease-free survival is now more than 7 years. In seven of nine patients, tumor recurred between 1.5 months and 48 months after transplantation. Conclusions: Patients with otherwise untreatable symptomatic neuroendocrine hepatic metastases of pancreatic origin may benefit from total hepatectomy and liver transplantation with regard to symptomatic relief and long-term survival, despite frequent recurrence of disease. In some patients, liver transplantation may even offer the chance for cure.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条
  • [31] Role of liver transplantation in the management of metastatic neuroendocrine tumors
    Fernández, JA
    Robles, R
    Marín, C
    Hernández, Q
    Bueno, FS
    Ramírez, P
    Rodríguez, JM
    Luján, JA
    Navalón, JC
    Parrilla, P
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1832 - 1833
  • [32] Results of Liver Transplantation in the Treatment of Metastatic Neuroendocrine Tumors
    Kotulski, Marcin
    Nyckowski, Pawel
    Krawczyk, Marek
    LIVER TRANSPLANTATION, 2010, 16 (06) : S197 - S197
  • [33] LONG TERM SURVIVAL, AFTER LIVER TRANSPLANTATION IN PATIENTS WITH NEUROENDOCRINE LIVER METASTASES: GERMAN SINGLE CENTER EXPERIENCE
    Homayounfar, Kia
    Goralczyk, Armin
    Becker, Heinz
    Ramadori, Giuliano
    Lorf, Thomas
    Obed, Aiman
    LIVER TRANSPLANTATION, 2009, 15 (07) : S148 - S148
  • [34] Outcomes Following Liver Transplantation for Metastatic Neuroendocrine Tumors
    Grat, M.
    Remiszewski, P.
    Smoter, P.
    Wronka, K. M.
    Grat, K.
    Lewandowski, Z.
    Koperski, L.
    Gornicka, B.
    Pacho, R.
    Zborowska, H.
    Patkowski, W.
    Krawczyk, M.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (08) : 2766 - 2769
  • [35] Proceed with caution: Liver transplantation for metastatic neuroendocrine tumors
    Knechtle, SJ
    Kalayoglu, M
    DAlessandro, AM
    Rikkers, LF
    ANNALS OF SURGERY, 1997, 225 (04) : 345 - 346
  • [36] Is there a Role for Liver Transplantation in Treatment of Metastatic Neuroendocrine Tumors?
    Annamalai, Alagappan A.
    Menon, Vijay G.
    Puri, Vichin C.
    Bresee, Catherine
    Leong, Trista
    Wolin, Edward M.
    Nissen, Nicholas N.
    Colquhoun, Steven D.
    HEPATOLOGY, 2012, 56 : 520A - 520A
  • [37] Multivisceral Transplantation to Treat Advanced Neuroendocrine Tumors in Gastrointestinal Tract: Experience at a Single Transplantation Center
    Lin, Jingmei
    Mangus, Richard
    House, Michael
    Cummings, Oscar
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A322 - A322
  • [38] TRANSPLANTATION OF THE LIVER FOR METASTATIC ENDOCRINE TUMORS OF THE INTESTINE AND PANCREAS
    MAKOWKA, L
    TZAKIS, AG
    MAZZAFERRO, V
    TEPERMAN, L
    DEMETRIS, AJ
    IWATSUKI, S
    STARZL, TE
    SURGERY GYNECOLOGY & OBSTETRICS, 1989, 168 (02): : 107 - 111
  • [39] Liver transplantation for primary and metastatic hepatic malignancy: a single center experience
    Tevar, AD
    Succop, P
    Schneider, CR
    Thambi-Pillai, T
    Thomas, MJ
    Neff, G
    Weber, F
    Rudich, SM
    Woodle, ES
    Buell, JF
    SURGERY, 2006, 139 (04) : 535 - 541
  • [40] Neuroendocrine tumors detected in appendectomy specimens: ten-year single-center experience
    Senel, Fatma
    Karaman, Hatice
    Demir, Hacer
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (01) : 68 - 73